Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Isobe

Showing results (381-390 of 389) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 389 results.
Gut|July 26, 2008
IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's diseaseT Kobayashi, S Okamoto, T Hisamatsu, et al.
International Journal of Oncology|July 31, 1999
Radiotherapy for large hepatocellular carcinoma combined with transcatheter arterial embolization and percutaneous ethanol injection therapyS Yasuda, H Ito, M Yoshikawa, et al.
International Journal of Molecular Medicine|April 11, 2001
Cell killing and mutation induction by heavy ion beamsN Shigematsu, N Ihara, T Kawata, et al.
Biochemical and Biophysical Research Communications|March 27, 1999
A mitochondrial DNA mutation cosegregates with the pathophysiological U waveR Matsuoka, M Furutani, J Hayashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1981
[Acute lymphoblastic leukemia of T-precursor cell--special reference to surface marker (author's transl)]K Kawashima, Y Kato, M Ogura, et al.
Rapid Communications in Mass Spectrometry : RCM|August 27, 2010
Delta15N of soil N and plants in a N-saturated, subtropical forest of southern ChinaK Koba, K Isobe, Y Takebayashi, et al.
Tissue Antigens|July 1, 1997
A strong association between HLA-B*5101 and Behçet's disease in Greek patientsN Mizuki, S Ohno, H Ando, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2000
Treatment for pyothorax-associated lymphomaT Aruga, J Itami, K Nakajima, et al.
ESMO Open|October 12, 2024
A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039AA Mouri, A Kisohara, R Morita, et al.
Pageof 39

Showing results (381-390 of 389) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 389 results.
Gut|July 26, 2008
IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's diseaseT Kobayashi, S Okamoto, T Hisamatsu, et al.
International Journal of Oncology|July 31, 1999
Radiotherapy for large hepatocellular carcinoma combined with transcatheter arterial embolization and percutaneous ethanol injection therapyS Yasuda, H Ito, M Yoshikawa, et al.
International Journal of Molecular Medicine|April 11, 2001
Cell killing and mutation induction by heavy ion beamsN Shigematsu, N Ihara, T Kawata, et al.
Biochemical and Biophysical Research Communications|March 27, 1999
A mitochondrial DNA mutation cosegregates with the pathophysiological U waveR Matsuoka, M Furutani, J Hayashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1981
[Acute lymphoblastic leukemia of T-precursor cell--special reference to surface marker (author's transl)]K Kawashima, Y Kato, M Ogura, et al.
Rapid Communications in Mass Spectrometry : RCM|August 27, 2010
Delta15N of soil N and plants in a N-saturated, subtropical forest of southern ChinaK Koba, K Isobe, Y Takebayashi, et al.
Tissue Antigens|July 1, 1997
A strong association between HLA-B*5101 and Behçet's disease in Greek patientsN Mizuki, S Ohno, H Ando, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2000
Treatment for pyothorax-associated lymphomaT Aruga, J Itami, K Nakajima, et al.
ESMO Open|October 12, 2024
A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039AA Mouri, A Kisohara, R Morita, et al.
Pageof 39